Trieu Vuong 4
4 · Oncotelic Therapeutics, Inc. · Filed Jan 31, 2025
Insider Transaction Report
Form 4
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
- Purchase
Common Stock
2025-01-30$0.03/sh+100,003$2,800→ 93,125,785 total - Purchase
Common Stock
2025-01-31$0.03/sh+63,775$1,786→ 93,189,560 total - Purchase
Common Stock
2025-01-29$0.03/sh+183,066$5,126→ 93,025,782 total
Holdings
- 6,872,529(indirect: By Spouse)
Common Stock
- 16,780,384(indirect: By Autotelic, Inc.)
Common Stock